KPC Global Medical Centers, INC.
KPC Global Medical Centers, INC. was paid $29.34M by Medicaid between Jan 2018 and Dec 2024, across 244 billing codes. Its largest line is 0450, Emergency room services — 16% of everything it billed.
HEMET, CA 92543
Next to other General Acute Care Hospital providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 177,222 | $4.03M | |
| 2019 | 205,087 | $4.38M | |
| 2020 | 165,147 | $3.86M | |
| 2021 | 167,064 | $4.32M | |
| 2022 | 165,997 | $4.41M | |
| 2023 | 178,462 | $4.57M | |
| 2024incomplete | 154,836 | $3.75M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 16% | 96,179 | 82,706 | $4.78M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.5% | 54,304 | 48,312 | $2.78M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.2% | 24,964 | 22,784 | $1.53M |
| 70450 | Computed tomography, head or brain; without contrast material | 5.1% | 11,678 | 11,251 | $1.49M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.9% | 18,265 | 17,168 | $1.13M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.9% | 5,277 | 5,129 | $1.13M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.9% | 32,771 | 29,929 | $849K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 27,777 | 24,836 | $842K |
| 80053 | Comprehensive metabolic panel | 2.5% | 58,433 | 52,195 | $736K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 64,418 | 56,597 | $587K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.8% | 3,184 | 3,112 | $539K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.8% | 4,964 | 4,851 | $524K |
232 more codes
| Z7502 | 1.7% | 14,974 | $502K | |
| 99070 | 1.6% | 70,308 | $478K | |
| 84484 | 1.6% | 33,020 | $470K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 7,634 | $393K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.2% | 9,468 | $353K |
| 99499 | 1.2% | 5,807 | $338K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.1% | 4,246 | $321K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 4,047 | $312K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.1% | 5,809 | $312K |
| 71045 | Radiologic examination, chest; single view | 1.0% | 27,242 | $296K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,576 | $281K |
| 82330 | <1% | 12,509 | $278K | |
| 81001 | <1% | 40,995 | $267K | |
| 99284 | Emergency room visit (serious) | <1% | 3,387 | $257K |
| J3490 | Unclassified drugs | <1% | 54,734 | $239K |
| 0360 | <1% | 2,221 | $236K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 3,899 | $223K |
| 99285 | Emergency room visit (most serious) | <1% | 1,725 | $221K |
| 93971 | <1% | 2,098 | $200K | |
| 0762 | <1% | 1,958 | $194K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,915 | $190K |
| 70486 | <1% | 1,256 | $186K | |
| 59025 | Fetal non-stress test | <1% | 9,466 | $182K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,377 | $177K |
| 83880 | <1% | 8,479 | $175K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,168 | $171K |
| 83690 | <1% | 18,546 | $163K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,486 | $159K |
| 85730 | <1% | 22,076 | $146K | |
| 76830 | Ultrasound, transvaginal | <1% | 2,278 | $146K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,666 | $144K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 381 | $140K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,922 | $115K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 659 | $110K |
| 76801 | <1% | 1,856 | $109K | |
| 72131 | <1% | 866 | $108K | |
| L8699 | Prosthetic implant, not otherwise specified | <1% | 64 | $107K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 5,027 | $106K |
| 85610 | <1% | 23,836 | $100K | |
| 82947 | <1% | 14,520 | $99K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,518 | $90K |
| 87088 | <1% | 13,098 | $86K | |
| 81025 | <1% | 11,687 | $82K | |
| 83605 | <1% | 5,282 | $80K | |
| 83735 | <1% | 10,833 | $79K | |
| 90715 | <1% | 2,317 | $75K | |
| 73130 | <1% | 2,778 | $72K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,805 | $71K |
| 84295 | <1% | 10,847 | $70K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,330 | $70K |
| 84132 | <1% | 10,913 | $69K | |
| 82565 | <1% | 10,624 | $69K | |
| 84702 | <1% | 4,019 | $68K | |
| G0378 | Hospital observation service, per hour | <1% | 1,073 | $68K |
| 87070 | <1% | 5,598 | $67K | |
| 73564 | <1% | 2,454 | $67K | |
| 82435 | <1% | 10,625 | $66K | |
| 73610 | <1% | 2,664 | $66K | |
| 72128 | <1% | 577 | $65K | |
| 99221 | <1% | 453 | $63K | |
| 74178 | <1% | 244 | $63K | |
| 73630 | <1% | 2,670 | $63K | |
| 0710 | <1% | 2,016 | $62K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,097 | $62K |
| 86677 | <1% | 3,004 | $61K | |
| 84520 | <1% | 10,634 | $61K | |
| 87040 | <1% | 3,069 | $59K | |
| 73030 | <1% | 2,418 | $59K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 16,906 | $57K |
| 73110 | <1% | 1,774 | $52K | |
| 76770 | <1% | 709 | $51K | |
| 87186 | <1% | 4,551 | $50K | |
| 84703 | <1% | 4,038 | $50K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 19,298 | $45K |
| 74018 | <1% | 2,149 | $41K | |
| 82803 | <1% | 1,703 | $40K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,328 | $40K |
| Z7610 | <1% | 6,991 | $39K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,999 | $37K |
| 85014 | <1% | 10,722 | $35K | |
| 71250 | <1% | 260 | $35K | |
| 93970 | <1% | 218 | $34K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,411 | $34K |
| 87077 | <1% | 5,362 | $31K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 870 | $31K |
| 73080 | <1% | 1,116 | $30K | |
| 82150 | <1% | 3,279 | $29K | |
| 12001 | <1% | 1,563 | $28K | |
| 86756 | <1% | 1,568 | $28K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 4,402 | $27K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 694 | $27K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 8,578 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 845 | $24K |
| 82140 | <1% | 1,843 | $23K | |
| 73090 | <1% | 962 | $20K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,283 | $19K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,859 | $18K |
| 71101 | <1% | 534 | $18K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 279 | $16K |
| 12011 | <1% | 617 | $16K | |
| 99218 | <1% | 91 | $16K | |
| 85379 | <1% | 1,258 | $15K | |
| 81003 | <1% | 5,193 | $15K | |
| 73502 | <1% | 578 | $14K | |
| 72100 | <1% | 530 | $14K | |
| 29125 | <1% | 1,457 | $13K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 7,377 | $13K |
| 86901 | <1% | 2,406 | $12K | |
| 73590 | <1% | 626 | $12K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,732 | $12K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,807 | $12K |
| 99152 | <1% | 292 | $11K | |
| 12002 | <1% | 615 | $11K | |
| 86850 | <1% | 1,480 | $11K | |
| 73140 | <1% | 657 | $11K | |
| 86900 | <1% | 2,427 | $9K | |
| 86920 | <1% | 68 | $9K | |
| 29515 | <1% | 835 | $8K | |
| 74022 | <1% | 226 | $8K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,166 | $8K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 560 | $7K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,823 | $7K |
| Z9725 | <1% | 210 | $6K | |
| 82550 | <1% | 727 | $6K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 87 | $6K |
| 0250 | <1% | 6,830 | $6K | |
| 99217 | <1% | 137 | $5K | |
| 76870 | <1% | 98 | $5K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 747 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 401 | $5K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 183 | $5K |
| 85378 | <1% | 537 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,191 | $5K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,052 | $4K |
| 94060 | <1% | 140 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,598 | $4K |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | <1% | 172 | $4K |
| 0270 | <1% | 1,540 | $4K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,368 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,078 | $4K |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 13 | $4K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,234 | $4K |
| J1815 | Injection, insulin, per 5 units | <1% | 1,329 | $3K |
| 29505 | <1% | 247 | $3K | |
| 84439 | <1% | 477 | $3K | |
| 81000 | <1% | 582 | $3K | |
| 94729 | <1% | 94 | $3K | |
| 72110 | <1% | 81 | $3K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 263 | $3K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 41 | $3K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 707 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 93 | $3K |
| 73562 | <1% | 126 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 18 | $2K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 56 | $2K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 12 | $2K |
| J1631 | Injection, haloperidol decanoate, per 50 mg | <1% | 138 | $2K |
| 99199 | Unlisted special service, procedure or report | <1% | 43 | $2K |
| 86703 | <1% | 153 | $2K | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 1,097 | $2K |
| 86140 | <1% | 296 | $2K | |
| 82010 | <1% | 173 | $2K | |
| 99224 | <1% | 26 | $2K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 383 | $2K |
| 94726 | <1% | 49 | $2K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 16 | $2K |
| 94760 | <1% | 235 | $2K | |
| 80320 | <1% | 1,320 | $1K | |
| 80061 | Lipid panel | <1% | 135 | $1K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 800 | $1K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 810 | $1K |
| 87205 | <1% | 249 | $1K | |
| 84145 | <1% | 65 | $1K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 625 | $1K |
| 88304 | <1% | 105 | $1K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 29 | $1K |
| 96367 | <1% | 15 | $1K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 203 | $1K |
| 82728 | <1% | 70 | $1K | |
| 85651 | <1% | 340 | $1K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 968 | $959.88 |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 22 | $864.22 |
| 29130 | <1% | 93 | $846.93 | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 734 | $832.43 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 146 | $827.56 |
| 72040 | <1% | 32 | $751.88 | |
| 29105 | <1% | 63 | $735.16 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 933 | $714.81 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,961 | $642.30 |
| 77336 | <1% | 28 | $594.84 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 182 | $582.10 |
| 51702 | <1% | 55 | $579.39 | |
| 72050 | <1% | 13 | $555.64 | |
| 71020 | <1% | 18 | $496.82 | |
| 83615 | <1% | 68 | $474.53 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 143 | $463.70 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 43 | $407.84 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 98 | $399.98 |
| 73552 | <1% | 13 | $385.33 | |
| 84100 | <1% | 94 | $382.78 | |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | <1% | 17 | $369.60 |
| 90714 | <1% | 12 | $359.19 | |
| 71010 | <1% | 22 | $349.46 | |
| J1956 | Injection, levofloxacin, 250 mg | <1% | 163 | $326.53 |
| 96368 | <1% | 13 | $320.01 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 82 | $316.71 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 87 | $306.43 |
| 80164 | <1% | 13 | $303.61 | |
| 94727 | <1% | 12 | $271.74 | |
| 94664 | <1% | 15 | $251.28 | |
| 73060 | <1% | 12 | $245.21 | |
| 73120 | <1% | 12 | $225.11 | |
| 96376 | <1% | 442 | $217.80 | |
| 85384 | <1% | 16 | $212.44 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 53 | $179.87 |
| A4217 | Sterile water/saline, 500 ml | <1% | 12 | $174.90 |
| 86780 | <1% | 12 | $158.32 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 30 | $149.57 |
| 84550 | <1% | 16 | $95.94 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 23 | $86.34 |
| 82570 | <1% | 15 | $83.00 | |
| 83986 | <1% | 13 | $66.76 | |
| 80329 | <1% | 392 | $60.45 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 36 | $44.74 |
| 87168 | <1% | 12 | $44.63 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 19 | $32.37 |
| 85007 | <1% | 13 | $24.42 | |
| J2704 | Injection, propofol, 10 mg | <1% | 200 | $19.01 |
| 0258 | <1% | 140 | $9.24 | |
| J0461 | Injection, atropine sulfate, 0.01 mg | <1% | 14 | $8.56 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 28 | $3.95 |
| Q4051 | Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Trusted Nurse Staffing | Buffalo, NY | $85.30M |
| Victor Valley Hospital Acquisition, INC. | Victorville, CA | $26.63M |
| KPC Global Medical Centers, INC. | Sun City, CA | $8.91M |
| Orange County Global Medical Center, INC | Santa Ana, CA | $8.60M |
| Pediatric and Adolescent Dentistry, LLC | Birmingham, AL | $5.29M |
| South Coast Global Medical Center, INC | Santa Ana, CA | $4.53M |
| Anaheim Global Medical Center, INC | Anaheim, CA | $4.29M |
| South Coast Global Medical Center, INC | Santa Ana, CA | $3.98M |
| Chapman Global Medical Center, INC | Orange, CA | $2.92M |
| Chapman Global Medical Center, INC | Orange, CA | $761K |
| New Creek Family Medicine PLLC | Keyser, WV | $580K |
| Delaware Neurology Associates,pa | Lewes, DE | $75K |
| Anaheim Global Medical Center, INC | Anaheim, CA | $20K |
| Orange County Global Medical Center, INC | Santa Ana, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.